Iralukast sodium

• CAT Number: I011858
• CAS Number: 125617-94-9
• Molecular Formula: C38 H37 F3 O8 S . Na
• Molecular Weight: 733.76
• Purity: ≥95%
• Synonyms: iralukast; CGP 45715A
• Target: Leukotriene Receptor
• Storage: -20°C
• IUPAC Name: sodium;7-[(1R,2S,3E,5Z)-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-1-hydroxy-1-[3-(trifluoromethyl)phenyl]deca-3,5-dien-2-yl]sulfanyl-4-oxochromene-2-carboxylate
• InChI: InChI=1S/C38H37F3O8S.Na/c1-3-11-29-31(18-17-27(23(2)42)36(29)45)48-19-9-7-5-4-6-8-14-34(35(44)24-12-10-13-25(20-24)38(39,40)41)50-26-15-16-28-30(43)22-33(37(46)47)49-32(28)21-26;/h4,6,8,10,12-18,20-22,34-35,44-45H,3,5,7,9,11,19H2,1-2H3,(H,46,47);/q;+1/p-1/b6-4-,14-8+;/t34-,35+;/m0./s1
• InChIKey: UVMDAJYLEKEIPJ-RWRWEHELSA-M
• SMILES: CCCC1=C(C=CC(=C1O)C(=O)C)OCCCC/C=C\C=C\[C@@H]([C@@H](C2=CC(=CC=C2)C(F)(F)F)O)SC3=CC4=C(C=C3)C(=O)C=C(O4)C(=O)[O-].[Na+]

Iralukast sodium（Cat No.:I011858）is a selective leukotriene receptor antagonist used in the management of asthma and allergic rhinitis. It works by blocking the action of leukotrienes, which are inflammatory mediators involved in the constriction of airways and increased mucus production in the lungs. By inhibiting leukotriene receptors, iralukast helps reduce inflammation, bronchoconstriction, and other asthma symptoms. It is often used as an adjunctive therapy alongside other medications, such as inhaled corticosteroids, to improve lung function and reduce the frequency of asthma attacks. Iralukast sodium has demonstrated efficacy in improving respiratory health.